Successful Deceased Donor Liver Transplantation with Postoperative Klebsiella Pneumonia Treatment

PACE Hospitals

PACE Hospitals’ expert Liver Transplant Team successfully performed a Deceased Donor Liver Transplantation (DDLT) on a 52-year-old female patient diagnosed with decompensated chronic liver disease and liver cirrhosis, possibly associated with non-alcoholic steatohepatitis. The procedure aimed to replace the severely damaged liver, restore liver function, prevent further life-threatening complications, and improve the patient’s overall survival and quality of life.


Chief Complaints

A 52-year-old female patient with a body mass index (BMI) of 21 presented to the Liver Transplant Department at PACE Hospitals, Hitech City, Hyderabad, with jaundice and recurrent episodes of intermittent fever for the past 4 months.

Past Medical History

The patient was a known case of decompensated chronic liver disease. Liver biopsy findings were suggestive of advanced liver cirrhosis, possibly related to non-alcoholic steatohepatitis. She also had chronic obstructive pulmonary disease (COPD) as an associated medical condition.

On Examination

On examination, the patient was conscious, coherent, oriented, and hemodynamically stable. Evident icterus was noted, with yellowish discoloration of the eyes. She appeared clinically unwell in the background of decompensated chronic liver disease and recurrent fever. A complete abdominal, cardiovascular, respiratory, and neurological examination was performed as part of the liver transplant assessment.

Diagnosis

Upon admission to PACE Hospitals, the Liver Transplant team conducted a comprehensive evaluation based on the patient’s complaints of persistent jaundice and intermittent fever in the background of known decompensated chronic liver disease.


A detailed medical history, physical examination, laboratory investigations, imaging studies, and liver biopsy were performed to assess the severity and possible cause of liver damage. The liver biopsy showed distorted liver architecture with complete nodular formation and fibrous bands containing inflammatory cells, findings consistent with advanced liver cirrhosis.


Based on the clinical and biopsy findings, the patient was diagnosed with decompensated liver cirrhosis, possibly secondary to non-alcoholic steatohepatitis. Chronic obstructive pulmonary disease was also considered during the pre-transplant evaluation.


Based on the confirmed diagnosis and severity of liver dysfunction, the patient was advised to undergo Decompensated Liver Cirrhosis Treatment in Hyderabad, India, under the specialised care of the Liver Transplant Department.

Medical Decision-Making (MDM)

After a detailed consultation with Dr. CH Madhusudhan (Senior Consultant Surgical Gastroenterologist and Liver Transplant Surgeon), and cross consultation with Dr. Govind Verma (Senior Consultant Interventional Gastroenterologist and Hepatologist) and Dr. Suresh Kumar S (Consultant Surgical Gastroenterologist), the patient underwent a comprehensive clinical, laboratory, imaging, and pre-anaesthesia evaluation. Her history of persistent jaundice, intermittent fever, decompensated chronic liver disease, biopsy-confirmed cirrhosis, and associated chronic obstructive pulmonary disease was carefully reviewed to determine the most appropriate treatment plan.


Considering the advanced liver damage and risk of further life-threatening complications, the liver transplant team determined that liver transplantation was the most appropriate definitive treatment. As no suitable living donor was available within the family, the patient was registered under the Jeevandan deceased organ donation programme in Telangana.


When a suitable deceased donor liver became available, compatibility, recipient fitness, and necessary medical clearances were assessed. The patient was stabilised and prepared for Deceased Donor Liver Transplantation.


The patient and her family were counselled regarding the severity of the liver disease, the transplant procedure, possible risks and complications, postoperative intensive care, infection and rejection risks, long-term anti-rejection medicines, and the importance of regular follow-up after transplantation.

Surgical Procedure

Following the decision, the patient was scheduled to undergo Deceased Donor Liver Transplantation (DDLT) in Hyderabad at PACE Hospitals under the expert care of the Liver Transplant team.


The procedure involved the following steps:


  • Preoperative Preparation and Anaesthesia: After completing the required investigations, donor compatibility assessment, medical clearances, and pre-anaesthesia evaluation, the patient was taken up for transplantation under general anaesthesia with continuous monitoring.


  • Abdominal Exploration and Liver Mobilisation: The abdominal cavity was accessed, and the diseased liver was carefully assessed and mobilised from the surrounding structures while controlling bleeding and protecting nearby organs.


  • Removal of the Diseased Liver: The major blood vessels and bile duct connected to the native liver were carefully identified and controlled. The severely damaged liver was then removed to prepare the recipient site for transplantation.


  • Donor Liver Graft Implantation: The deceased donor liver graft obtained was positioned in the recipient’s abdomen.


  • Vascular and Biliary Reconstruction: The donor liver blood vessels were connected to the recipient’s vessels to restore blood flow to the graft. The bile duct was reconstructed to allow normal drainage of bile from the transplanted liver.


  • Graft Assessment and Closure: After confirming satisfactory graft perfusion and controlling bleeding, the abdomen was closed in layers. The procedure was completed without reported intraoperative complications, and the patient was shifted to the intensive care unit for close postoperative monitoring.

Postoperative Care

After surgery, the patient was closely monitored for transplanted liver function, blood clotting, breathing, infection, and overall recovery. She later developed fever, cough with sputum, and required prolonged oxygen support. Sputum culture identified Klebsiella pneumoniae infection, which was treated with appropriate medical management under specialist care.


She received medicines to protect the transplanted liver and prevent rejection, control infection, provide gastric protection, support nutrition, prevent vomiting, and relieve pain and fever. Anti-rejection medicine doses were adjusted according to liver function test results. After clinical improvement and hemodynamic stabilisation, she was discharged with medications and follow-up advice.

Discharge Medications

Upon discharge, the patient was advised to take medicines to protect the transplanted liver and prevent rejection, along with medicines to treat and prevent infection. She was also prescribed medicines for gastric protection, nutritional support, nausea control, pain relief, fever control, and other supportive care.

Advice on Discharge

The patient was advised to take all medicines on time, maintain proper hygiene, avoid exposure to infections, and follow the liver transplant team’s instructions carefully. Regular follow-up was advised to monitor liver function, respiratory recovery, and anti-rejection medicine levels.

Emergency Care

The patient was advised to contact the emergency ward at PACE Hospitals in case of the development of symptoms such as fever, worsening cough, breathing difficulty, abdominal pain, repeated vomiting, worsening jaundice, confusion, bleeding, reduced urine output, wound-related concerns, or any sudden deterioration in her condition.

Review and Follow-Up Notes

The patient was advised to return for a follow-up visit with the Surgical Gastroenterologist in Hyderabad at PACE Hospitals to monitor transplanted liver function, respiratory recovery, infection status, wound healing, and anti-rejection medicine levels.

Conclusion

This case highlights the successful management of decompensated liver cirrhosis through Deceased Donor Liver Transplantation. The postoperative Klebsiella pneumoniae respiratory infection was identified and treated promptly, following which the patient improved and was discharged in a stable condition with medications and follow-up advice.

Managing Respiratory Infection After Deceased Donor Liver Transplantation

Patients are more vulnerable to infections after liver transplantation because anti-rejection medicines reduce immune system activity. Fever, persistent cough, sputum production, breathing difficulty, or increased oxygen requirement therefore need prompt assessment. Early investigations, including sputum culture, can help identify the organism causing the infection and guide appropriate treatment. In this case, Klebsiella pneumoniae infection was identified and managed with targeted antibiotics, oxygen support, and close respiratory monitoring. Coordinated care involving the Liver Transplant doctor/specialist, pulmonology, critical care, and nursing teams helped control the infection while protecting graft function and supporting a safe recovery.

Frequently Asked Questions (FAQs)


  • How can non-alcoholic steatohepatitis lead to liver cirrhosis?

    Non-alcoholic steatohepatitis, or NASH, causes fat accumulation along with inflammation and damage to liver cells. If this damage continues for several years, scar tissue gradually replaces healthy liver tissue. Severe scarring can lead to cirrhosis, liver failure, and the possible need for liver transplantation.

  • What is deceased donor liver transplantation?

    Deceased donor liver transplantation is a procedure in which a diseased or failing liver is removed and replaced with a healthy liver donated by a person who has died. The donated liver is allocated according to medical suitability and transplant regulations. This procedure can be life-saving for patients with end-stage liver disease.

  • What tests are performed before deceased donor liver transplantation?

    Before transplantation, doctors perform blood tests, liver and kidney function tests, infection screening, blood-group testing, and imaging studies. Heart and lung assessments may include an ECG, echocardiogram, chest X-ray, and lung-function tests. These evaluations help determine whether the patient is medically fit to undergo major transplant surgery.

  • Why is a liver biopsy performed in patients with chronic liver disease?

    A liver biopsy is performed when blood tests and scans do not provide enough information about the cause or severity of liver disease. A small liver tissue sample is examined to identify inflammation, fat accumulation, fibrosis, or cirrhosis. The results can help doctors confirm the diagnosis and plan appropriate treatment.

  • How does COPD affect liver transplant planning and recovery?

    COPD can reduce lung capacity and increase the risk of breathing problems during and after major surgery. Therefore, lung function, oxygen levels, and chest findings are carefully assessed before transplantation. The respiratory condition may need to be stabilised, and the patient may require closer monitoring or longer oxygen support during recovery.

  • How can Klebsiella pneumoniae affect the lungs after liver transplantation?

    Klebsiella pneumoniae is a bacterium that can cause pneumonia, particularly in hospitalised or immunocompromised patients. It may lead to fever, cough with sputum, breathing difficulty, low oxygen levels, and the need for respiratory support. Some strains may be resistant to antibiotics, so early identification through culture testing is important.

  • How is a bacterial respiratory infection treated after liver transplantation?

    Treatment includes antibiotics selected according to sputum or blood culture results. The patient may also require oxygen, airway clearance, hydration, and close monitoring of breathing and graft function. Anti-rejection medicines should only be adjusted by the transplant team, as reducing them without medical supervision may increase the risk of liver rejection.

  • What warning symptoms should not be ignored after liver transplant surgery?

    Fever, worsening cough, breathing difficulty, abdominal pain, repeated vomiting, increasing jaundice, confusion, reduced urine output, bleeding, or wound discharge should not be ignored. These symptoms may indicate infection, rejection, bile-duct problems, or another complication. The transplant team should be contacted immediately for assessment.

  • Why is regular follow-up important after Deceased Donor Liver Transplantation?

    Regular follow-up allows doctors to monitor liver function, medicine levels, infection, rejection, wound healing, and other possible complications. Some problems may first appear through blood tests before the patient notices symptoms. Attending every scheduled review and taking anti-rejection medicines correctly are essential for protecting the transplanted liver.

  • Can patients recover well after developing an infection following liver transplantation?

    Yes, many patients can recover well when the infection is recognised early and treated appropriately. Recovery depends on the type and severity of infection, antibiotic sensitivity, the patient’s general health, lung condition, and transplanted liver function. Close monitoring and coordinated care by the transplant, pulmonology, and critical-care teams improve the chances of recovery.

Share on

Request an appointment

Fill in the appointment form or call us instantly to book a confirmed appointment with our super specialist at 04048486868

Appointment request - health articles

Recent Articles

Frey's procedure case study | chronic pancreatitis case study | PACE Hospitals case studies
By PACE Hospitals August 22, 2026
Explore the case study of a 22-year-old patient who recovered from chronic pancreatitis, pseudocyst, and duct disruption with the successful Frey's procedure at PACE Hospitals.
88-Y/O Somalian patient at PACE Hospitals, treated with total knee replacement for osteoarthritis
By PACE Hospitals August 21, 2026
Explore the case study of an 88-year-old Somalian patient at PACE Hospitals, treated with total knee replacement for osteoarthritis and a 90-degree flexion deformity, leading to improved mobility and pain relief post-surgery.
Case study of 17-YO patient who underwent ERCP treatment for chronic pancreatitis at PACE Hospitals
By PACE Hospitals August 20, 2026
Explore the successful case study of a 17-years-old male at PACE Hospitals, Hyderabad treated for chronic pancreatitis and pancreas divisum with ERCP, leading to significant pain relief and improved pancreatic function.
Case study of 69 YO male patient from Bhopal who successfully underwent the POEM procedure
By PACE Hospitals August 20, 2026
Explore the case study of a 69-year-old male patient from Bhopal who successfully underwent the POEM procedure for Achalasia Cardia Type II at PACE Hospitals, experiencing significant relief and recovery.
Case study of a 41-YO female who underwent successful living donor liver transplantation (LDLT)
By PACE Hospitals August 18, 2026
Explore this case study of a 41-year-old female who underwent successful living donor liver transplantation (LDLT) for decompensated chronic liver disease (DCLD) and associated complications at PACE Hospitals, with excellent outcomes.
 Case study of ABO incompatible kidney transplant of Madagascar patient at PACE Hospitals
By PACE Hospitals August 17, 2026
Explore the case study of a successful ABO incompatible kidney transplant for a foreign resident(Madagascar) at PACE Hospitals, overcoming challenges with precise care, expert surgical techniques, and improving the quality of life.